Albumedix Media News & Events Advanced Therapies Xchange 2023

Advanced Therapies Xchange 2023

03 Apr 2023

HubXchange East Coast is an excellent opportunity for Albumedix to highlight our collaborative approach and trusted products, which support cell and gene therapy development.

 

Looking for solutions that drive your cell and gene therapy from the bench to manufacture or beyond? Meet the team at hubXchange Boston on the 3rd of April at the Hilton Boston Woburn Hotel, 2 Forbes Road, Woburn, MA 01801.

 

Get in touch today to set aside some time at the event to learn how Albumedix and our Recombumin® portfolio can support your advanced therapy.

CONTACT

Albumedix Ltd.
Mabel Street
The Meadows
Nottingham
NG2 3ED, United Kingdom
Tel: +44 115 9553379
info@albumedix.com

 

Albumedix - Dedicated to Better Health

Albumedix is a science-driven company and recognized leader of best-in-class albumin-enabled solutions. Established in the UK in 1984, with a mission to empower excellence, Albumedix has supported its life-science partners to deliver hundreds of million safe doses of clinical and marketed therapeutics, globally. Albumedix’ solutions include the world’s only USP-NF compliant recombinant human albumin (Recombumin®), client-centric development and compliance services and drug-enhancing technologies (Veltis®). By always striving for more and collaboratively challenging status quo, Albumedix enables the development and commercialisation of advanced therapies and next-generation biopharmaceuticals to the benefit of people worldwide.

 

Privacy | Cookies | Patent Portfolio

ALBUMEDIX, the ALBUMEDIX LOGO, DEDICATED TO BETTER HEALTH and marks such as RECOMBUMIN and VELTIS are trademarks of Albumedix. Albumedix© Copyright 2018

FOLLOW US